Straits Times Index
3,308.85 +5.66 (+0.17%) Nikkei
38,650.66 +414.59 (+1.08%) Hang Seng
18,587.95 +9.65 (+0.05%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,748.95 -441.03 (-0.69%) CMC Crypto 200
1,374.30 +61.67 (+4.70%)
Nanobiotix S.A. (NBTX)
| Previous close | 6.10 |
| Open | 6.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 6.25 - 6.51 |
| 52-week range | 4.55 - 11.00 |
| Volume | |
| Avg. volume | 30,686 |
| Market cap | 297.743M |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
11 Best Nanotechnology Stocks To Invest In
In this piece, we will take a look at the 11 best nanotechnology stocks to invest in. If you want to skip our introduction to the nanotechnology sector and how it covers a variety of applications ranging from healthcare to consumer technology, then you can skip ahead to read 5 Best Nanotechnology Stocks To Invest […]
- GuruFocus.com
Baillie Gifford Bolsters Stake in Nanobiotix SA
Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently increased its investment in Nanobiotix SA, a company at the forefront of nanotechnology in cancer treatment. This transaction was executed at a trade price of $5.81 per share, reflecting a 48.18% change in the firm's holdings and a 6.21% ownership in Nanobiotix SA. Despite the significant addition, the trade had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the position accounting for just 0.02% of its total investments.
